Trial Profile
The prevention effect of ARB(Candesartan) upon chronic heart failure of the newly hemo-dialysis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2011
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Antihypertensives
- Indications Cardiovascular disorders; Chronic heart failure
- Focus Therapeutic Use
- 10 Nov 2011 New trial record